logo

For the Inventor, By the Inventor

Surry Hills, Australia

Peter Whitfeld

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: G2 Inflammation Pty Ltd. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Whitfeld. Retrieved from https://idiyas.com/inventor/peter-whitfeld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal3 out of 6 
 
G2 Inflammation Pty Ltd
 patents

Years Active: 2012-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 8808701 - Methods of inhibiting the interaction of C5aR with C5a with anti-C5aR antibodies (2014-08-19),
2. 8361468 - Humanized anti-C5aR antibodies (2013-01-29),
3. 8268972 - Humanized anti-C5aR antibodies (2012-09-18),

Title: The Innovations of Peter Whitfeld

Introduction

Peter Whitfeld is an accomplished inventor based in Surry Hills, Australia. He has made significant contributions to the field of therapeutic and diagnostic agents through his innovative work. With a total of 3 patents, Whitfeld has focused on developing humanized antibodies that target the human C5a receptor.

Latest Patents

Whitfeld's latest patents include groundbreaking methods for inhibiting the interaction of C5aR with C5a using anti-C5aR antibodies. These inventions are directed towards humanized antibodies that bind to the human C5a receptor, which can be utilized as therapeutic and diagnostic agents. Additionally, his patents encompass nucleic acid sequences that encode these humanized antibodies and their expression in recombinant host cells. Notably, these humanized antibodies are derived from the murine antibody 7F3, which specifically binds to the human C5a receptor.

Career Highlights

Peter Whitfeld is currently associated with G2 Inflammation Pty Ltd, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of inflammation and immune response.

Collaborations

Whitfeld collaborates with notable colleagues, including David Georges Zahra and Charles Reay Mackay, who contribute to his innovative projects and research initiatives.

Conclusion

Peter Whitfeld's contributions to the field of therapeutic and diagnostic agents through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…